NEW YORK, June 20, 2017 -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Booz Allen Hamilton Holding Corporation (“Booz Allen” or the “Company”) (NYSE:BAH) of the August 18, 2017 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
If you invested in Booz Allen stock or options between May 19, 2016 and June 15, 2017 and would like to discuss your legal rights, click here: www.faruqilaw.com/BAH. There is no cost or obligation to you.
You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected].
The lawsuit has been filed in the U.S. District Court for the Eastern District of Virginia on behalf of all those who purchased Booz Allen securities between May 19, 2016 and June 15, 2017 (the “Class Period”). The case Langley v. Booz Allen Hamilton Holding Corporation, et al., No. 17-cv-00696 was filed on June 19, 2017, and has been assigned to Judge Leonie M. Brinkema.
The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to maintain proper internal financial controls and accounting standards that led to inflated revenues from Company’s contracts with the U.S. government.
Specifically, after market closed on June 15, 2017, the Company announced that its subsidiary, Booz Allen Inc., “was informed that the U.S. Department of Justice is conducting a civil and criminal investigation relating to certain elements of the Company’s cost accounting and indirect cost charging practices with the U.S. government.”
After the announcement, Booz Allen’s share price fell from $39.33 per share on June 15, 2017 to a closing price of $31.90 on June 16, 2017—a $7.43 or an 18.9% drop.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Booz Allen’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
CONTACT: FARUQI & FARUQI, LLP 685 Third Avenue, 26th Floor New York, NY 10017 Attn: Richard Gonnello, Esq. [email protected] Telephone: (877) 247-4292 or (212) 983-9330


Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Anta Sports Expands Global Footprint With Strategic Puma Stake
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Amazon Explores AI Content Marketplace With Media Publishers
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Washington Post Publisher Will Lewis Steps Down After Layoffs
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



